Приказ основних података о документу
Computer aided drug design – a step closer to selective HDAC-6 inhibitor?
dc.creator | Ružić, Dušan | |
dc.creator | Nikolić, Katarina | |
dc.creator | Agbaba, Danica | |
dc.creator | Ganesan, A. | |
dc.date.accessioned | 2023-09-15T09:39:10Z | |
dc.date.available | 2023-09-15T09:39:10Z | |
dc.date.issued | 2016 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/5028 | |
dc.description.abstract | Histone deacetylases (HDACs) are epigenetic erasers, which are considered as transcriptional repressors and potent anticancer targets. Today, 18 human HDACs are identified and divided in four classes. FDA has approved four Histone Deacetylase Inhibitors (HDACi), defined as pan-HDAC inhibitors... | sr |
dc.language.iso | en | sr |
dc.publisher | Freiburg Institute for Advanced Studies | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS// | sr |
dc.relation | COST CM1406 action | sr |
dc.rights | restrictedAccess | sr |
dc.source | 3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13 | sr |
dc.title | Computer aided drug design – a step closer to selective HDAC-6 inhibitor? | sr |
dc.type | conferenceObject | sr |
dc.rights.license | ARR | sr |
dc.description.other | Poster | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_5028 | |
dc.type.version | publishedVersion | sr |